Efficacy is monitored through regular blood tests, bone marrow biopsies, and clinical assessments. Response to treatment can be evaluated using criteria such as complete remission (CR), partial remission (PR), and overall survival (OS). Molecular and cytogenetic studies may also be used to assess response to therapy.
